MESSENGER THERAPEUTICS Trademark

Trademark Overview

On Monday, January 3, 2022, a trademark application was filed for MESSENGER THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MESSENGER THERAPEUTICS trademark a serial number of 97200580. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, September 18, 2023. This trademark is owned by ModernaTx, Inc.. The MESSENGER THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics
messenger therapeutics

General Information

Serial Number97200580
Word MarkMESSENGER THERAPEUTICS
Filing DateMonday, January 3, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, September 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and Servicesscientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 6, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameModernaTx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, September 18, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, September 18, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, September 18, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, August 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 30, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 30, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 10, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 10, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 22, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, February 22, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, February 21, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, February 21, 2023FINAL REFUSAL E-MAILED
Tuesday, February 21, 2023FINAL REFUSAL WRITTEN
Tuesday, February 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 18, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 18, 2022NON-FINAL ACTION E-MAILED
Thursday, August 18, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 17, 2022ASSIGNED TO EXAMINER
Thursday, January 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 6, 2022NEW APPLICATION ENTERED

Related Keywords

therapeutics messenger biologics biotherapeutics biosimilars medicine vaccines research fields pharmaceuticals scientific